Mediwound Ltd (MDWD) FinancialsMDWDMediwound Ltd

Evaluating the bottom line, Mediwound Ltd maintains a gross margin of 10.90%. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at -305.89%, while the net margin is -239.07%. These profitability ratios, combined with a Return on Equity (ROE) of -55.25%, provide a clear picture of how effectively MDWD converts its operational activities into shareholder value.

In the context of the broader market, MDWD competes directly with industry leaders such as LENZ and OTLK. With a market capitalization of $170.93M, it holds a leading position in the sector. When comparing efficiency, MDWD's gross margin of 10.90% stands against LENZ's 94.90% and OTLK's -95.00%. Such benchmarking helps identify whether Mediwound Ltd is trading at a premium or discount relative to its financial performance.

Mediwound's financial performance shows a troubling trend with a Q2 2026 revenue of $3.1 million, a significant drop from $5.7 million in Q2 2025. The net loss for the same quarter was $7.4 million, compared to a loss of $13.3 million the previous year, indicating ongoing financial struggles despite slight improvements in loss management.